Trudel, S., Moreau, P., & Touzeau, C. (2019). Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: Patients’ selection and perspective. Onco Targets Ther.
Stile di citazione ChicagoTrudel, Sabrina, Philippe Moreau, e Cyrille Touzeau. "Update On Elotuzumab for the Treatment of Relapsed/refractory Multiple Myeloma: Patients’ Selection and Perspective." Onco Targets Ther 2019.
Citazione MLATrudel, Sabrina, Philippe Moreau, e Cyrille Touzeau. "Update On Elotuzumab for the Treatment of Relapsed/refractory Multiple Myeloma: Patients’ Selection and Perspective." Onco Targets Ther 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.